Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma

[1]  R. Parkkola,et al.  Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival , 2015, Journal of Neuro-Oncology.

[2]  A. Petzold.  Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease , 2015, Brain Research.

[3]  Yoshiyuki Suzuki,et al.  Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme. , 2015, Anticancer research.

[4]  G. Reifenberger,et al.  MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial , 2015, Clinical Cancer Research.

[5]  T. Jiang,et al.  Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[6]  K. Hoang-Xuan,et al.  Diagnostic and prognostic value of preoperative combined GFAP, IGFBP‐2, and YKL‐40 plasma levels in patients with glioblastoma , 2014, Cancer.

[7]  H. Zetterberg,et al.  Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. , 2014, Resuscitation.

[8]  C. Robertson,et al.  GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. , 2014, Journal of neurotrauma.

[9]  M. Röösli,et al.  Modulation of Age- and Cancer-Associated DNA Methylation Change in the Healthy Colon by Aspirin and Lifestyle , 2014, Journal of the National Cancer Institute.

[10]  Anne K. Braczynski,et al.  Confounding Factors in Diagnostics of MGMT Promoter Methylation Status in Glioblastomas in Stereotactic Biopsies , 2014, Stereotactic and Functional Neurosurgery.

[11]  Hester F. Lingsma,et al.  Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. , 2014, Journal of neurotrauma.

[12]  M. Toms,et al.  Biochemical markers of brain tumours. , 2013, Klinicheskaia laboratornaia diagnostika.

[13]  R. Lonser,et al.  Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. , 2013, Journal of neurosurgery.

[14]  H. Steinmetz,et al.  Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases , 2013, PloS one.

[15]  A. Unterberg,et al.  Diagnostic markers for glioblastoma. , 2011, Histology and histopathology.

[16]  N. Kushlinskii,et al.  Neurospecific Proteins in the Serum of Patients with Brain Tumors , 2011, Bulletin of Experimental Biology and Medicine.

[17]  K. Dietz,et al.  Spatio‐temporal deleted in colorectal cancer (DCC) and netrin‐1 expression in human foetal brain development , 2010, Neuropathology and applied neurobiology.

[18]  W. Pfeilschifter,et al.  Astroglial Proteins as Diagnostic Markers of Acute Intracerebral Hemorrhage—Pathophysiological Background and Clinical Findings , 2010, Translational Stroke Research.

[19]  H. Steinmetz,et al.  Serum GFAP is a diagnostic marker for glioblastoma multiforme. , 2007, Brain : a journal of neurology.

[20]  L. Rosengren,et al.  Serum levels of glial fibrillary acidic protein correlate to tumour volume of high‐grade gliomas , 2007, Acta neurologica Scandinavica.

[21]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[22]  Paola Pisani,et al.  Genetic Pathways to Glioblastoma , 2004, Cancer Research.

[23]  R. Bjerkvig,et al.  Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression , 2003, Oncogene.

[24]  L. Eng,et al.  Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000) , 2000, Neurochemical Research.

[25]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[26]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[27]  L. Eng.  Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes , 1985, Journal of Neuroimmunology.

[28]  A. Ferbert,et al.  Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. , 2012, Clinical chemistry.

[29]  A. Borit,et al.  Vimentin and glial fibrillary acidic protein in human brain tumors , 2004, Journal of Neuro-Oncology.